Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries India Globalization Capital Inc (NY: IGC ) 0.4124 +0.0073 (+1.80%) Official Closing Price Updated: 8:00 PM EDT, Jul 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about India Globalization Capital Inc < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > IGC Pharma Reports Third Quarter Fiscal 2024 Results February 16, 2024 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Reports Data from Preclinical Studies Indicating Proprietary Drug Candidate Reduces Agitation in Alzheimer’s Mouse Model February 01, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model February 01, 2024 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Reports Data Showing Proprietary Drug Candidate TGR-63 Reduces Plaque in Alzheimer’s January 23, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s January 23, 2024 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Activates ClinCloud in Phase 2b Alzheimer’s Trial January 17, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial January 17, 2024 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Receives ‘Milestone’ Patent for Drug Formulation Used to Treat Agitation in Alzheimer’s December 19, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s December 19, 2023 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) to Participate at Biotech Showcase and BioPartnering @ JPM December 13, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024 December 13, 2023 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Partners with Prominent Center to Integrate AI into Clinical Trials December 06, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials December 06, 2023 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Enters Strategic Collaboration to Advance AI Initiatives November 21, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives November 21, 2023 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Q2 2024 Financial, Corporate Report November 13, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property IGC Pharma Reports Second Quarter Fiscal 2024 Results November 13, 2023 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Cannabinoid-Based Topical Pain-Relief Treatment Receives European Patent October 20, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy October 19, 2023 From IGC Pharma, Inc. Via Business Wire 420 with CNW — Study Suggests Marijuana Users Are Less Predisposed to Type 2 Diabetes August 22, 2023 Via Investor Brand Network Topics Cannabis Exposures Cannabis 420 with CNW — Study Suggests Marijuana Users Are Less Predisposed to Type 2 Diabetes August 22, 2023 Via CannabisNewsWire Topics Cannabis Exposures Cannabis BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces Results of Annual Meeting August 21, 2023 Via Investor Brand Network Topics Regulatory Compliance Exposures Legal Regulatory IGC Announces Results of its 2023 Annual Stockholders Meeting August 21, 2023 From IGC Pharma, Inc. Via Business Wire 420 with CNW — AMA Study Finds Marijuana Smoking Viewed as Safer Than Cigarette Smoking August 21, 2023 Via CannabisNewsWire Topics Cannabis Exposures Cannabis 420 with CNW — AMA Study Finds Marijuana Smoking Viewed as Safer Than Cigarette Smoking August 21, 2023 Via Investor Brand Network Topics Cannabis Exposures Cannabis 420 with CNW — LA Mayor to Announce Head of City Marijuana Agency August 18, 2023 Via CannabisNewsWire Topics Cannabis Exposures Cannabis 420 with CNW — LA Mayor to Announce Head of City Marijuana Agency August 18, 2023 Via Investor Brand Network Topics Cannabis Exposures Cannabis 420 with CNW — Gallup Poll Finds Highest Ever Support for Cannabis Legalization Among Republicans August 17, 2023 Via Investor Brand Network Topics Cannabis Exposures Cannabis 420 with CNW — Gallup Poll Finds Highest Ever Support for Cannabis Legalization Among Republicans August 17, 2023 Via CannabisNewsWire Topics Cannabis Exposures Cannabis 420 with CNW — Cannabis Industry Lobbying Increases as Looming Government Shutdown Leaves SAFE Banking in Balance August 16, 2023 Via Investor Brand Network Topics Cannabis Exposures Cannabis < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.